About the bill
- Full Title
To clarify that the overall trade negotiating objectives of the United States include avoiding provisions in trade agreements that restrict the access of consumers in the United States to pharmaceutical imports, and for other purposes.
The bill’s title was written by its sponsor.
Read CRS Summary >
Jul 28, 2005
This is the first step in the legislative process.
Read Text »
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 3583”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
10 cosponsors (6D, 3R, 1I)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Related Bills
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jul 28, 2005
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 3583 — 109th Congress: Protecting Free Trade in Pharmaceuticals Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr3583
“H.R. 3583 — 109th Congress: Protecting Free Trade in Pharmaceuticals Act of 2005.” www.GovTrack.us. 2005. February 13, 2016 <https://www.govtrack.us/congress/bills/109/hr3583>
|title=H.R. 3583 (109th)
|accessdate=February 13, 2016
|author=109th Congress (2005)
|date=July 28, 2005
|quote=Protecting Free Trade in Pharmaceuticals Act of 2005